Formula & Concentration
CABLIVI (caplacizumab-yhdp) for injection, for intravenous or subcutaneous use
CABLIVI is a von Willebrand factor (vWF)-directed antibody fragment indicated for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.
Shelf Life & Storage
Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
Do not freeze.
Unopened vials may be stored in the original carton at room temperature up to 30°C (86°F) for a single period of up to 2 months.
o not return CABLIVI to the refrigerator after it has been stored at room temperature.